Successful Treatment of Cystic/Conglobata Acne and Dermal Fibrotic Lesions with Regenerative Cell Therapy

This case demonstrates the successful treatment of cystic/conglobata acne and dermal fibrotic lesions with regenerative cell therapy in a patient who had previously failed conventional treatments. By targeting the underlying inflammatory processes and promoting tissue regeneration, regenerative therapy offered sustained relief and clear skin without the need for immunosuppressive medications. Further research and clinical studies are warranted to validate these findings and optimize treatment protocols for acne and related dermatological conditions.

humanblu

Patient Information:

Age

31 years old

Gender

Male

Ethnicity

Asian

Medical History:

No medications, alcohol, tobacco, vaccines, allergies, or genetic diseases. Previous unsuccessful treatments with isotretinoin, spironolactone, and broad-range antibiotics for cystic/conglobata acne.

Presenting Complaint:

He presented with early-stage cystic/conglobata acne accompanied by dermal fibrotic lesions on his face and upper back. Previous treatments, including isotretinoin, spironolactone, and antibiotics, had limited to no effect on his condition, prompting exploration of alternative therapies.

Treatment Approach:

In light of the failure of conventional treatments and the recommendation for immunosuppressive therapy, he opted for regenerative cell therapy. Over the course of eight weeks, he received four treatment sessions, with each session comprising five units of complete regenerative cell factors administered via intravenous infusion, subcutaneous injections, and topical application by micro-channel.

Clinical Course:

Following the completion of the initial treatment protocol, he experienced significant improvements in his condition. The regenerative cell therapy targeted both the underlying inflammatory processes contributing to cystic acne and the fibrotic lesions, aiming to promote tissue repair and regeneration.

Outcome:

The outcomes of the regenerative cell therapy were highly favorable for him:

Complete Remodeling of Scar Tissue: Within ten weeks of initiating treatment, he exhibited complete remodeling of the scar tissue associated with cystic acne and dermal fibrotic lesions. Visible lesions were no longer present on his face or upper back.

Sustained Clear Skin: Following the initial treatment protocol, he reported sustained clear skin without the need for any medications. This long-term improvement indicated the efficacy and durability of the regenerative therapy in managing his condition.

Follow-Up:

He continued to be monitored periodically following the completion of the initial treatment protocol. His sustained clear skin and absence of lesions were confirmed during follow-up visits, supporting the long-term efficacy of the regenerative cell therapy.

Conclusion:

Reactivate Peak Performance.

Discover available options for suppliers and patients, get started with Cell Factors today